-
1Image
المؤلفون: Yael Rachamin (6161423), Christoph Jakob Ackermann (11707353), Oliver Senn (128287), Thomas Grischott (5863430)
مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Ecology, Cancer, Science Policy, Hematology, Infectious Diseases, tiered health care, searched public repositories, protein kinase inhibitors, mandatory health insurance, last 15 years, interquartile range 4, 2005 – 2009, 2005 &# 8211, rising launch prices, reimbursed oncological drugs, oncological drugs introduced, 2015 – 2019, 2005 – 2019, monoclonal antibodies ), div >< p, 483 – 7, mostly hematological drugs, major global concern, individual price developments, oncological drugs, individual drugs
-
2
المؤلفون: Yael Rachamin (6161423), Christoph Jakob Ackermann (11707353), Oliver Senn (128287), Thomas Grischott (5863430)
مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Ecology, Cancer, Science Policy, Hematology, Infectious Diseases, tiered health care, searched public repositories, protein kinase inhibitors, mandatory health insurance, last 15 years, interquartile range 4, 2005 – 2009, 2005 &# 8211, rising launch prices, reimbursed oncological drugs, oncological drugs introduced, 2015 – 2019, 2005 – 2019, monoclonal antibodies ), div >< p, 483 – 7, mostly hematological drugs, major global concern, individual price developments, oncological drugs, individual drugs
-
3Image
المؤلفون: Yael Rachamin (6161423), Christoph Jakob Ackermann (11707353), Oliver Senn (128287), Thomas Grischott (5863430)
مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Ecology, Cancer, Science Policy, Hematology, Infectious Diseases, tiered health care, searched public repositories, protein kinase inhibitors, mandatory health insurance, last 15 years, interquartile range 4, 2005 – 2009, 2005 &# 8211, rising launch prices, reimbursed oncological drugs, oncological drugs introduced, 2015 – 2019, 2005 – 2019, monoclonal antibodies ), div >< p, 483 – 7, mostly hematological drugs, major global concern, individual price developments, oncological drugs, individual drugs
-
4Image
المؤلفون: Yael Rachamin (6161423), Christoph Jakob Ackermann (11707353), Oliver Senn (128287), Thomas Grischott (5863430)
مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Ecology, Cancer, Science Policy, Hematology, Infectious Diseases, tiered health care, searched public repositories, protein kinase inhibitors, mandatory health insurance, last 15 years, interquartile range 4, 2005 – 2009, 2005 &# 8211, rising launch prices, reimbursed oncological drugs, oncological drugs introduced, 2015 – 2019, 2005 – 2019, monoclonal antibodies ), div >< p, 483 – 7, mostly hematological drugs, major global concern, individual price developments, oncological drugs, individual drugs
-
5Image
المؤلفون: Yael Rachamin (6161423), Christoph Jakob Ackermann (11707353), Oliver Senn (128287), Thomas Grischott (5863430)
مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Ecology, Cancer, Science Policy, Hematology, Infectious Diseases, tiered health care, searched public repositories, protein kinase inhibitors, mandatory health insurance, last 15 years, interquartile range 4, 2005 – 2009, 2005 &# 8211, rising launch prices, reimbursed oncological drugs, oncological drugs introduced, 2015 – 2019, 2005 – 2019, monoclonal antibodies ), div >< p, 483 – 7, mostly hematological drugs, major global concern, individual price developments, oncological drugs, individual drugs
-
6
المؤلفون: Yael Rachamin (6161423), Christoph Jakob Ackermann (11707353), Oliver Senn (128287), Thomas Grischott (5863430)
مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Ecology, Cancer, Science Policy, Hematology, Infectious Diseases, tiered health care, searched public repositories, protein kinase inhibitors, mandatory health insurance, last 15 years, interquartile range 4, 2005 – 2009, 2005 &# 8211, rising launch prices, reimbursed oncological drugs, oncological drugs introduced, 2015 – 2019, 2005 – 2019, monoclonal antibodies ), div >< p, 483 – 7, mostly hematological drugs, major global concern, individual price developments, oncological drugs, individual drugs
-
7Dissertation/ Thesis
Thesis Advisors: Piscoya, Alejandro
المصدر: Universidad Peruana de Ciencias Aplicadas (UPC)Repositorio Académico - UPC.
مصطلحات موضوعية: Actividad física, Obesidad, Conocimientos, Actitudes y prácticas en salud, Sobrepeso, Motivación, Physical Activity, Obesity, Health Knowledge, Attitudes and Practice, Overweight, Motivation, Background. The focus of this study is to determine if a correlation exists between knowing the consequences that may arise from obesity and the level of a person’s physical activity. Methods. A cross-sectional study performed on a group of 215 students was conducted in 2013 and 2014. The students were selected by convenience sampling at a university in Lima, Peru. The level of physical activity was measured using the International Physical Activity Questionnaire (IPAQ), and the knowledge that each student had about the consequences of obesity was assessed using the Obesity Risk Knowledge-10 scale (ORK-10). Each student was also asked to record the source where they obtained what information they knew. Results. The median age of the participants was 20 (interquartile range=4), and 63% of the participants were female. According to the IPAQ, 53.9% of the participants recorded high levels of physical activity, 35.4% recorded moderate levels, and 10.7%, recorded low levels. While a low correlation between the ORK- 10 score and the amount of METs/minute/week spent was found (rs=0,06), it was not significant (p=0.38). We found that people who were informed by the media or healthcare personnel achieved higher scores at the ORK-10 scale than those who used other sources of information (p<0,05). Conclusions. There is a very low correlation between the knowledge about the consequences of obesity and a person’s level of physical activity. A multidisciplinary approach that includes all of the determinants of physical activity performance is necessary in order to attain changes in people’s behavior.